Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus haloperidol for delirium/agitation during ventilator weaning in ICU patients
ACTRN12606000085572Phase 3Terminated
- Sponsor
- Prince of Wales Hospital
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in delirium comparing Haloperidol with Dexmedetomidine (2 arms). Primary endpoints: Number of patients extubated and Sedation or delirium control at 36 hours. Started Mar 2006; status: terminated.
02
Drugs
dexmedetomidinehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12606000085572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000085572.